PM Modi’s dilemma: To begin Vaccine Maitri or raise stocks

Tribune News Service

Advertisement

New Delhi, September 15

India will face the dilemma of either living up to its own billing as the pharmacy of the world or opting to vaccinate a large chunk of the population before taking a call on exports.

The occasion will be a Covid global summit in New York, where PM Narendra Modi is likely to share the stage with the host, US President Joe Biden, besides other world leaders who have played a major role in assisting other countries during the pandemic.

On Sunday, US Surgeon General Vivek Murthy said Biden would announce new steps to slow the spread of Covid.

India, too, will be obliged to step up new plans to help the world build on its now-interrupted Vaccine Maitri initiative that saw the Foreign Ministry set up a special dashboard as planes took off to different parts of the world loaded, first with medicines, and later vaccines.

The halt to exports of India-made AstraZeneca vaccine, one of the cheapest in the market, left many countries without an adequate number of doses.

The pressure on existing vaccine manufacturers comes at a time when the Quad grouping of the US, India, Japan and Australia have fallen behind in their plans to start vaccinating the world from 2022.

The US is reluctant to back an India-South Africa proposal before the WTO for a limited time waiver on patents on vaccines and Covid medicines. This will permit rapid and low-cost manufacturing of many of these items in developing countries.